Frazier Lifesciences Acquisition Corp. (FLACU)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
BLANK CHECKS
CEO:
James N. Topper, PhD
Employees:
4
TWO UNION SQUARE, 601 UNION STREET, SUITE 3200, SEATTLE, WA 98101
617-570-8364

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses in the biotechnology sector.

Data derived from most recent annual or quarterly report
Market Cap 72.44 Million Shares Outstanding7.625 Million Avg 30-day Volume 7.26 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.54
Price to Revenue0.0 Debt to Equity0.0 EBITDA-4.449 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value315.342 Million
Current Ratio0.117 EPS Growth0 Quick Ratio0.099
1 Yr BETA 0.2463 52-week High/Low 10.8 / 8.07 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score8.4429 Free Cash Flow to Firm 0
View SEC Filings from FLACU instead.

View recent insider trading info

Frazier Lifesciences Acquisition Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding FLACU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FLACU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-11-25 by VIKING GLOBAL INVESTORS LP
  • 3: filed on 2022-11-14 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
  • 4: filed on 2022-11-04 by VIKING GLOBAL INVESTORS LP
  • 3: filed on 2022-11-04 by VIKING GLOBAL INVESTORS LP
  • 3/A: filed on 2020-12-17 by HERON PATRICK J
  • 3/A: filed on 2020-12-17 by TOPPER DAVID JOSEPH
  • 3/A: filed on 2020-12-17 by BIGHAM MICHAEL
  • 3/A: filed on 2020-12-17 by BALTERA ROBERT JR.
  • 3/A: filed on 2020-12-17 by Polu Krishna R
  • 3/A: filed on 2020-12-17 by GALLAGHER CAROL GILTNER

    • Events (8k)

  • 8-K: filed on 2022-11-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-07-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-26:
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
  • 8-K: filed on 2021-05-24:
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
  • 8-K: filed on 2021-01-29:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    VIKING GLOBAL INVESTORS LP

    VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

    VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

    VIKING GLOBAL OPPORTUNITIES GP LLC

    VIKING GLOBAL OPPORTUNITIES PARENT GP LLC

    HALVORSEN OLE ANDREAS

    OTT DAVID C.

    SHABET ROSE SHARON

    • 10% Owner
    		 0 2022-11-22 3

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 2,480,199 2022-11-08 1

    BIGHAM MICHAEL

    • Director
    		 0 2020-12-08 0

    GALLAGHER CAROL GILTNER

    • Director
    		 0 2020-12-08 0

    TOPPER JAMES N CHIEF EXECUTIVE OFFICER

    FRAZIER LIFESCIENCES SPONSOR LLC

    FRAZIER LIFE SCIENCES X, L.P.

    FHMLS X, L.P.

    FHMLS X, L.L.C.

    HERON PATRICK J

    • Officer
    • Director
    • 10% Owner
    		 0 2020-12-08 0

    BALTERA ROBERT JR.

    • Director
    		 0 2020-12-08 0

    POLU KRISHNA R

    • Director
    		 0 2020-12-08 0

    TOPPER DAVID JOSEPH CHIEF FINANCIAL OFFICER

    • Officer
    • Director
    		 0 2020-12-08 0

    NOWICKI MAX N. VICE PRESIDENT, ACQUISITIONS

    • Officer
    		 0 2020-12-08 0

    EMPEY GORDON VICE PRESIDENT&GENERAL COUNSEL

    • Officer
    		 0 2020-12-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 22:15:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 21:45:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 21:15:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 20:45:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 20:15:04 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 19:45:04 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 19:15:04 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 18:45:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 18:15:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 17:45:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 17:15:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 16:45:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 16:15:04 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 15:45:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 15:15:03 UTC -33.9162 37.7362 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 14:45:04 UTC 2.5242 1.2958 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 14:15:03 UTC 2.5242 1.2958 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 13:45:03 UTC 2.5242 1.2958 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 13:15:03 UTC 2.5242 1.2958 800
    FRAZIER LIFESCIENCES ACQUIS FLACU 2022-11-23 12:45:03 UTC 2.5242 1.2958 800

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments